Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.100
+0.020 (1.85%)
At close: Jun 26, 2026, 4:00 PM EDT
1.090
-0.010 (-0.91%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 112 employees as of December 31, 2025. The number of employees decreased by 22 or -16.42% compared to the previous year.
Employees
112
Change (1Y)
-22
Growth (1Y)
-16.42%
Revenue / Employee
n/a
Profits / Employee
-$758,339
Market Cap
90.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Adicet Bio | 102 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| ImmuCell | 73 |
| Rani Therapeutics Holdings | 71 |
| NeurAxis | 24 |
INO News
- 24 days ago - Inovio Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 27 days ago - Inovio price target lowered to $2.50 from $3 at H.C. Wainwright - TheFly
- 4 weeks ago - INOVIO to Participate in Upcoming Scientific and Investor Conferences - PRNewsWire
- 5 weeks ago - Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100 - TheFly
- 5 weeks ago - Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China - PRNewsWire
- 5 weeks ago - Inovio Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Inovio Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Inovio Pharmaceuticals Quarterly report: Q1 2026 - Filings